C253383: DHSC_OHID_HPV_Self-Sampling_cost effectiveness model

Tender description

The Department of Health and Social Care is looking to award a contract for HPV Self-sampling Cost Effectiveness Model. Deliverables will include the following: • Model Specifications: Development of a model to determine the conditions under which the introduction of self-sampling in the cervical screening programme provides the most benefits in terms of clinical outcomes for women and cost-effectiveness for the programme. • Cost effectiveness model: Running of model and analysis of cost-effectiveness. • Model Technical Report: Interim report(s) by Spring 2025, to feed into the ISE design process. • Model: Final report(s) in Spring 2026 clearly outlining model type, analytical approach, assumptions, uncertainties, results, and discussion, including implications to policy. • It is expected that the final paper is published in a peer-reviewed journal to highlight the high-quality and robust work required. • Transfer of the model's outputs to the UK NSC Initial contract term: 18 months. Extension: The contract may be extended for a period of 6 months. Estimated value for the contract: £250,000 exclusive of VAT - £300,000. The DHSC is issuing this early engagement to seek information and feedback from the market to gain better understanding of the intelligence, budget cap and appetite for this project. For avoidance of doubt this is not a call for competition, the purpose is to advise the market on the forthcoming DHSC procurement and seek feedback from suppliers that may inform the final specification and/or procurement approach to the services. This market engagement process do not form part of the formal procurement process. When the formal procurement process commences any supplier may join the competition and all supplier bids will be evaluated on the same basis. A Market Engagement Questionnaire and draft Specifications are attached to this notice. The completed questionnaire should be returned via email ccsinbox@dhsc.gov.uk quoting 'HPV Self-sampling Cost Effectiveness Model' no later than 26th March 2024, 5pm.